Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The in-vitro colorectal cancer screening tests market was valued at USD 971.30 Million in 2025. It is poised to grow at a CAGR of 5.53% during the forecast period of 2026-2035, reaching USD 1663.84 Million by 2035. The market is driven by the rising prevalence of colorectal cancer globally, growing adoption of minimally invasive colorectal cancer screening procedures, and increasing government-backed early detection initiatives across developed and emerging economies.
Market Size and Forecast
- Market Size (2025): USD 971.30 Million
- Projected Market Size (2035): USD 1663.84 Million
- CAGR (2026-2035): 5.53%
Key Market Trends and Insights
- By test type, the biomarker tests segment is expected to grow at the fastest CAGR of 5% in the forecast period.
- By end user, the diagnostic laboratories are likely to hold the largest share in the forecast period.
- North America dominated the market with a revenue share of nearly 39% in the historical period.
Read more about this report - Request a Free Sample
In-Vitro Colorectal Cancer Screening Tests Market Overview
In-vitro colorectal cancer screening tests are diagnostic procedures performed outside the body to detect adenomas, polyps, and early markers of colorectal cancer. Common tests include fecal occult blood tests (FOBT), fecal immunochemical tests (FIT), CRC DNA screening tests, and biomarker tests. As per Expert Market Research (EMR), the market was valued at USD 971.30 Million in 2025, driven by the expanding access to non-invasive colon cancer screening protocols, advancements in liquid biopsy platforms, and rising awareness about the benefits of early detection of colorectal cancer, collectively driving market expansion.
In-Vitro Colorectal Cancer Screening Tests Market Growth Drivers
Rising Prevalence of Colorectal Cancer Fuels Demand for Early-Stage Diagnostic Solutions
Colorectal cancer remains one of the most prevalent malignancies worldwide, ranking as the third most diagnosed cancer globally. According to the World Health Organization (WHO), colorectal cancer accounts for nearly 10% of all cancer-related deaths, with incidence continuing to rise due to aging populations, sedentary lifestyles, and dietary changes. This growing burden is directly fuelling adoption of fecal occult blood tests, fecal immunochemical tests (FIT), and CRC DNA screening tests as frontline diagnostic tools.
Read more about this report - Request a Free Sample
In-Vitro Colorectal Cancer Screening Tests Market Growth Trends
The market is witnessing a strong trend toward non-invasive, highly sensitive diagnostic technologies.
Technological Advancements in Non-Invasive Diagnostics are Reshaping the Colorectal Cancer Screening Landscape
The market is witnessing a significant shift toward non-invasive screening solutions driven by patient preference for convenience and improved compliance. The development of advanced stool DNA tests, liquid biopsy platforms, and next-generation sequencing tools is improving sensitivity in the early detection of colorectal cancer. Blood-based biomarker tests such as Guardant Health's Shield test are broadening diagnostic capabilities. In February 2023, researchers at the University of Technology Sydney (UTS) developed a microfluidic device capable of detecting cancer cells from blood samples. This representing a notable advancement in non-invasive cancer diagnostics and liquid biopsy technologies with potential applications in colorectal cancer detection.
In-Vitro Colorectal Cancer Screening Tests Market Segmentation
Market Breakup by Test Type
- Fecal Occult Blood Test (FOBT)
- Guaiac FOBT
- Immuno-FOBT (FIT)
- Stool DNA Test (sDNA)
- Colonoscopy
- Flexible Sigmoidoscopy
- CT Colonography (Virtual Colonoscopy)
- Biomarker Tests
- CEA Tests
- Others
Market Breakup by Technology
- Tumor Biomarker-Based Tests
- Guaiac-Based Tests
- Immuno-FOBT (FIT)
- DNA-Based Tests
- Colonoscopy Technology
- Others
Market Breakup by Collection Method
- Guaiac Sampling
- Immuno-FOBT Sampling
- Stool DNA Sampling
- Blood Sampling (for Biomarker Tests)
- Others
Market Breakup by End User
- Hospitals
- Diagnostic Laboratories
- Ambulatory Surgical Centers
- Research Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Read more about this report - Request a Free Sample
In-Vitro Colorectal Cancer Screening Tests Market Share
Biomarker Tests Segment is Expected to Witness the Fastest Growth Based on the Test Type
The market is segmented by test type into fecal occult blood test (FOBT), guaiac FOBT, immuno-FOBT (FIT), stool DNA test (sDNA), colonoscopy, flexible sigmoidoscopy, colonography (virtual colonoscopy), biomarker tests, CEA tests, and others. Among these, the biomarker tests segment is expected to witness the fastest growth during the forecast period, driven by rising demand for highly sensitive and minimally invasive colorectal cancer diagnostics. Increasing adoption of blood-based cancer screening technologies and advancements in molecular diagnostics are further supporting segment expansion. The growing burden of colorectal cancer is accelerating the need for early and accurate screening solutions, thereby strengthening demand for advanced biomarker-based testing approaches.
Read more about this report - Request a Free Sample
In-Vitro Colorectal Cancer Screening Tests Market Analysis by Region
North America leads the global in-vitro colorectal cancer screening tests market, supported by advanced healthcare infrastructure, high colorectal cancer prevalence, and well-established national screening programs. The region benefits from strong regulatory frameworks and growing adoption of at-home fecal immunochemical test (FIT) kits. Asia Pacific is expected to register the fastest growth, driven by rising colorectal cancer incidence, improving healthcare access, and expanding reimbursement coverage for colon cancer screening procedures.
Read more about this report - Request a Free Sample
Leading Players in the In-Vitro Colorectal Cancer Screening Tests Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Abbott Laboratories
Abbott Laboratories is actively involved in colorectal cancer diagnostics through its broad oncology assay portfolio, including CEA biomarker assays and fecal occult blood testing solutions used in early cancer detection. The company’s Alinity and ARCHITECT platforms support laboratories with reliable in-vitro diagnostic capabilities, strengthening its presence in colorectal cancer screening and clinical oncology testing worldwide.
F. Hoffmann-La Roche AG
F. Hoffmann-La Roche AG plays a significant role in colorectal cancer diagnostics through its advanced pathology and molecular diagnostic solutions. The company offers VENTANA immunohistochemistry and in situ hybridization assays that support cancer biomarker detection and tissue analysis. Roche continues to strengthen laboratory efficiency and diagnostic accuracy through its automated in-vitro diagnostic platforms and oncology-focused assay portfolio.
Siemens Healthineers AG
Siemens Healthineers AG is a key player in the in-vitro colorectal cancer screening tests market, engaged in the colorectal cancer screening and oncology diagnostics sector through its extensive range of immunoassays and laboratory testing systems. The company provides oncology assay solutions and biomarker-based diagnostic technologies that assist healthcare professionals in cancer detection and disease monitoring. Its integrated diagnostic platforms enhance laboratory workflow efficiency and support precision-driven clinical decision-making.
Biohit Oyj
Biohit Oyj is a Finnish biotechnology company actively involved in the in-vitro colorectal cancer screening tests market through its innovative gastrointestinal diagnostic solutions. The company offers fecal occult blood testing products and related screening technologies designed to support early detection of gastrointestinal disorders and colorectal cancer. Biohit continues to strengthen its presence in the market by focusing on cost-effective, non-invasive diagnostic innovations that improve screening accessibility and clinical efficiency.
Other key player includes Epigenomics AG, Randox Laboratories Ltd., QIAGEN N.V., Eiken Chemical Co., Ltd., Novigenix AI SA, and Exact Sciences Corporation.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Key Questions Answered in the In-Vitro Colorectal Cancer Screening Tests Market Report
- What was the in-vitro colorectal cancer screening tests market value in 2025?
- What is the in-vitro colorectal cancer screening tests market forecast outlook for 2026-2035?
- What major factors aid the demand for the in-vitro colorectal cancer screening tests market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major in-vitro colorectal cancer screening tests market trends?
- Which test type is expected to dominate the market segment?
- Which technology is projected to lead the market segment?
- Which collection method is anticipated to drive the market segment?
- Which end user is likely to dominate the market segment?
- Who are the key players in the in-vitro colorectal cancer screening tests market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by Technology |
|
| Breakup by Collection Method |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
